Herbert Schmid

Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase

Vito Guagnano, Pascal Furet, Carsten Spanka et al. · Journal of Medicinal Chemistry · 2011 · 489 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Improving Oral Bioavailability of Peptides by Multiple N‐Methylation: Somatostatin Analogues

Éric Biron, Jayanta Chatterjee, Oded Ovadia et al. · Angewandte Chemie International Edition · 2008 · 372 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistance

Camille Duluc, Siham Moatassim-Billah, Mounira Chalabi‐Dchar et al. · EMBO Molecular Medicine · 2015 · 196 citations · Full text

Medicine, Oncology, Pharmacology +15

Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Trafficking in Vitro

Sarah Lesche, Diana Lehmann, Falko Nagel et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 167 citations

Medicine, Endocrinology, Molecular Biology +17

Functional Activity of the Multiligand Analog SOM230 at Human Recombinant Somatostatin Receptor Subtypes Supports Its Usefulness in Neuroendocrine Tumors

Herbert Schmid, Philippe Schoeffter · Neuroendocrinology · 2004 · 165 citations

Medicine, Endocrinology, Pharmacology +15